Clinical Trials Where World Class Care Begins

Similar documents
Comprehensive Protocol Feasibility Questionnaire

Documenting the Story of a Clinical Trial: Concept to CAPA. Lori T. Gilmartin Gilmartin Consulting LLC

Clinical Trial Readiness Checklist October 2014

MMC-Einstein Research IT Forum

ACTIONS/PSOP/001 Version 1.0 Page 2 of 6

Dr. R. Sathianathan. Role & Responsibilities of Principal Investigators in Clinical Trials. 18 August 2015

Protocol Feasibility and Operationalization Framework. Beth Harper, BS, MBA. President, Clinical Performance Partners, Inc.

Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network for Research Professionals

Presented by NC TraCS Institute UNC Office of Clinical Trials UNC Network of Clinical Research Professionals

August 3, 2017 Clinical Trials at UNC. UNC Symposium for Research Administrators

Review & Negotiation Process for Sponsor & Investigator Initiated Clinical Trial Agreements

INVESTIGATOR-INITIATED CLINICAL TRIALS AWARD PROGRAM

Investigator-Initiated Studies: When you re the Sponsor. Cheri Robert & Tammy Mah-Fraser

MMC-Einstein Research IT Forum

4.2. Clinical Trial Monitor (or Monitor): The person responsible for monitoring the data on behalf of the sponsor or contract research organization.

Unofficial copy not valid

SUCCESS FEE FOR SERVICE PROGRAMS

St. James s Hospital Research Governance and Support Framework

Effective Date: 11/09 Policy Chronicle:

General Administration GA STANDARD OPERATING PROCEDURE FOR Sponsor Responsibility and Delegation of Responsibility

Clinical Research Professionals

Study Start-Up SS STANDARD OPERATING PROCEDURE FOR PRE-STUDY SITE VISIT (PSSV)

A Principal Investigator s Guide to Responsibilities, Qualifications, Records and Documentation of Human Research University of Kentucky

Research Audits PGR. Effective: 12/04/2013 Reviewed: 12/04/2015. Name of Associated Policy: Palmetto Health Administrative Research Review

Institutional Review Board (previously referred to as Human Participants Research Board) Updated January 2004

Nursing Home. 30(b)(6) Deposition Notice

HIC Standard Operating Procedure. For-Cause Audits of Human Research Studies

PHS Interventional Study Operational Approval Request

STANDARD OPERATING PROCEDURE

2017 Clinical Trials Data Library

Study Responsibilities. Choose all that apply. f. Draw/collect laboratory specimens

Clinical Trial Budgeting and Negotiation March 2018

Vertex Investigator-Initiated Studies Program Overview

Ab o r i g i n a l Operational a n d. Revised

Research & Funding A Step-by-Step Guide

Regulatory Binder Checklist for FDA-Regulated Sponsor/Sponsor-Investigator Studies

IRB 101. Rachel Langhofer Joan Rankin Shapiro Research Administration UA College of Medicine - Phoenix

Administrators. Medical Directors. 61% The negative impact on our hospital-based program s. 44% We will need to consider the most appropriate or most

University of Kansas Medical Center Research Institute What Every Administrator Ought to Know About Grant Management

Project Expense Considerations. Study Budgeting Considerations Research Staff and Trainees Expense Projected Expense Estimated Cost & Notes

Document Title: Site Selection and Initiation for RFL Sponsored Studies Document Number: 026

STANDARD OPERATING PROCEDURE SOP 710. Good Clinical Practice AUDIT AND INSPECTION. NNUH UEA Joint Research Office. Acting Research Services Manager

Loyola University Chicago Health Sciences Division Maywood, IL. Human Subject Research Project Start-Up Guide

Good Clinical Practice: A Ground Level View

The GCP Perspective on Study Monitoring

WEST PENN ALLEGHENY HEALTH SYSTEM

UCLA INNOVATION FUND PROCESS...

University of Illinois at Chicago Human Subjects Protection Program Plan

CLOSE OUT VISIT REPORT (NO CRF TO MONITOR)

SERVICE LEVEL AGREEMENT: University of Arkansas for Medical Sciences OFFICE OF SPONSORED PROGRAMS ADMINISTRATIVE NETWORK (OSPAN)

Trial Management: Trial Master Files and Investigator Site Files

STANDARD OPERATING PROCEDURE SOP 325

Record or Document Type Retention Period Relevant Legal Citation(s) IRB Records: Training Records;

MONTEFIORE MEDICAL CENTER The University Hospital for the Albert Einstein College of Medicine

managing or activities.

UNIVERSITY MEDICAL CENTER NEW ORLEANS RESEARCH REVIEW APPLICATION

RESEARCH 101: THE KEYS TO GETTING APPROVAL & CONDUCTING RESEARCH AT GRADY. MARCH 22, 2018 Presented By: The Offices of Research & Grant Administration

Hertfordshire Hospitals R&D Consortium Incorporating West Herts Hospitals NHS Trust and East & North Herts NHS Trust

Study Management PP STANDARD OPERATING PROCEDURE FOR Safeguarding Protected Health Information

Risk-Quality-Safety Management Reporting and the Healthcare SafetyZone Portal

ADVOCATE HEALTH CARE GUIDELINES FOR VENDOR RELATIONS

SOP: New Revised Reviewed Effective Date: 08 October Approved by : Supervisor/Manager Risk/Ethics Sr. Mgmt Committees Board/Councils

ETHICS COMMITTEE: ROLE, RESPONSIBILITIES AND FUNCTIONS K.R.CHANDRAMOHANAN NAIR DEPARTMENT OF ANATOMY, MEDICAL COLLEGE, THIRUVANANTHAPURAM

Proposed amendments to the Marihuana for Medical Purposes Regulations

Career Development Fellowships 2018 Guidelines for Applicants. Applications close 12 noon 05 April 2018

Local VA VA ORD CSP Other VA ORD. IRB of Record Registration Number: IRB Operated by: Local VA Non-local VA Academic Affiliate VHA Central IRB

Homecare Salary & Benefits Report Job Descriptions. Salary Positions

MMC-Einstein Research IT Forum. November 6, 2017

Setting up a CITI account for users not enrolled at or employed by Georgia Tech. Georgia Institute of Technology December 2016

COMPETENCY FRAMEWORK

The Clinical Investigation Policy and Procedure Manual Document: CIPP

BIMO SITE AUDIT CHECKLIST

This Agreement dated DD/MM/YYYY (the Effective Date ) is between

Underlying principles of the CVS Caremark Formulary Development and Management Process include the following:

Executive Director. Health Improvement Partnership April 2009 Duty Statement page 1

University of Kansas Medical Center Research Institute. What Every Administrator Ought to Know About Grant Management

Section 11. Recruitment of Study Subjects (Revised 7/1/10)

UNIVERSITY RESEARCH ADMINISTRATION FINANCIAL ROLES AND RESPONSIBILITIES MATRIX - WORK IN PROGRESS 10/03/2013 Roles.

1. Department of Defense (DoD) Human Subjects Protection Regulatory Requirements

General Procedure - Institutional Review Board

Site Closedown Checklist for UoL Sponsored CTIMP Studies

12.0 Investigator Responsibilities

Version Number: 004 Controlled Document Sponsor: Controlled Document Lead:

Corporate Research Policy I. SCOPE:

Title: OFFICE OF SPONSORED PROGRAMS/IRB/ORIP COORDINATION

Compliance Policy C-FMS Clinical Research Project Approval Application

Implementation of the Healthy Islands monitoring framework: Health information systems

Sponsored Program Administration Policy Approved by Academic Senate on 4/4/06

Defense Health Agency PROCEDURAL INSTRUCTION

Research Policy. Date of first issue: Version: 1.0 Date of version issue: 5 th January 2012

Roles of Investigators in the Managements of Clinical Trials

SOP16: Standard Operating Procedure for Establishing Sites and Centres - Site Setup

Wage Subsidy Community Coordinator

Demystifying the IRB

PSC Certification: What really happens

DANA-FARBER / HARVARD CANCER CENTER POLICIES FOR HUMAN SUBJECT RESEARCH TITLE:

The Clinical Research Center Research Practice Manual. Guideline for Study Document and Data Handling RPG-08. Guideline. Purpose.

ELECTIVE COMPETENCY AREAS, GOALS, AND OBJECTIVES FOR POSTGRADUATE YEAR ONE (PGY1) PHARMACY RESIDENCIES

NATIONAL ASSOCIATION FOR STATE CONTROLLED SUBSTANCES AUTHORITIES (NASCSA) MODEL PRESCRIPTION MONITORING PROGRAM (PMP) ACT (2016) COMMENT

Center for Health and Technology Telehealth Education Program. Executive Overview

Transcription:

Office of Clinical Trials Clinical Trials Where World Class Care Begins

We seek to attract novel, innovative and transformational research and devices to our medical center and its stakeholders, and serve as an easy partner giving industry sponsors access to our skilled investigators, our experienced study coordinators and our active and involved patient population. We offer: Business development for new trials Negotiation of Confidentiality and Non-Disclosure Agreements Contract negotiation and execution Budget preparation and negotiation assistance Regulatory support for institutional review board (IRB) submissions Post-award study finance management and invoicing Study coordinator training and education Patient recruitment and retention techniques and tools THE OFFICE OF CLINICAL TRIALS Opened in May 2011, the Office of Clinical Trials (OCT) serves Montefiore Medical Center and Albert Einstein College of Medicine in managing all aspects of clinical trials of pharmaceuticals and medical devices for both industry-sponsored and investigator-initiated studies. The mission of the Office of Clinical Trials is to encourage and support investigators at Einstein and Montefiore in the conduct of clinical research by providing resources, expertise and best practices to facilitate efficient, compliant and ethical study conduct and management. We strive to provide exceptional support to our physicians and to our community to foster better health outcomes for our patients and afford them access to state-of-the-art therapies and drugs. We help prepare IRB submissions, build and negotiate budgets, craft and negotiate contracts, and engage in business development. OCT is committed to serving the needs of our principal investigators (PIs) and their study coordinators as well as study sponsors, clinical research organizations (CROs), IRBs, regulatory agencies and patients. Activating a trial is a major undertaking for the investigator and team, and we provide guidance, assistance and counsel to facilitate all steps from budget building to study initiation. We are committed to eliminating barriers, waits and delays in clinical research and recognize that investigators need for support does not end when subject enrollment begins. We search nationwide for trials and best practices to bring to our investigators, our Centers of Excellence and our patient community.

STUDY BUDGET OCT collaboration and processing begin with a review of the visit schedule of your protocol. This review, done with the PI and sponsor, is required to determine which procedures are considered purely for research and which are considered standard of care as part of a formal Medicare Coverage Analysis. The PI and the research team are intimately involved with the budgetary process. We examine all budgetary planning and proposed charges and fees prior to execution of the Clinical Trial Agreement (CTA) to ensure competitive and adequate reimbursement for trial work and patient needs, as well as inclusion of appropriate fees and overhead. OCT oversees the process to be sure planned expenses include appropriate costs for tests and procedures, hospitalizations, equipment, staffing, IRB fees, storage and institutional overhead. We help you to identify the proper charges for each of these fees, which include but are not limited to Clinical Research Center (CRC) fees, startup fees, pharmacy and radiology fees, and study site activation charges. THE CLINICAL TRIAL AGREEMENT Clinical Trial Agreements are legal documents that define specifically what will be done, to whom and when, as well as who will be responsible for costs and sequelae thereof. OCT manages, negotiates and finalizes contracting between sponsor and investigator. The final contract includes the mutually agreed upon budget as an amendment to the contract itself. Legal counsel is available within OCT and attends to all PI research and team legal issues. REGULATORY DOCUMENT AND IRB SUBMISSION We help with study and research team submissions of required regulatory documents and assist in preparing the IRB package. An OCT Regulatory Specialist works closely with the PI, study coordinator, IRB and Sponsor/CRO. Our goal is to reduce the number of outstanding items to be addressed after an initial IRB review and facilitate a more rapid IRB approval. IRBs All research involving human subjects must be approved by an IRB. The IRB is charged with protecting the rights and welfare of subjects in all research studies. We will work with you in navigating your path through the IRB, be it the Einstein IRB or the Biomedical Research Alliance of New York (BRANY) IRB. STARTUP PROCESS To initiate the process of activating a clinical trial, the OCT needs to be notified of your intent. This is done via completion of a formal STUDY ACTIVATION form, available at www.einstein.yu.edu/centers/ictr/clinical-trials. For a new study protocol application: If your trial is industry-sponsored, submit your protocol with the STUDY ACTIVATION FORM to OCT@montefiore.org or OCT@einstein.yu.edu. Your department head s signature is required on your request, both to ensure that he or she is informed of the trial and to confirm approval. For more information regarding initial submission of Clinical Trial Studies, visit OCT s website: www.einstein.yu.edu/centers/ictr/clinicaltrials. STUDY MANAGER REVEAL The Office of Clinical Trials uses Study Manager Reveal, a clinical trials Internet-based management system used to track and account for the work of trials that we administer. This system allows our office to record study information; store and organize electronic documents; schedule and track patient appointments; administer budgets; manage financials, invoicing and collections; reconcile charges and payments; and generate customized reports. Study coordinators use this software to help manage their trials with their own protected usernames and passwords.

GREENPHIRE CLINCARD OCT uses a Web-based system Greenphire that enables subjects to be compensated for their time, travel and expenses in as little as one business day. This debit card system enables prompt subject compensation for any trial that is managed by OCT. With protected usernames and passwords, PIs and study coordinators are able to process reimbursements included in a study budget on the day of a subject s visit. Employing Greenphire will: Reduce paperwork and processing time for dispensed funds Increase subject retention and compliance Improve patient satisfaction STUDY TEAM AND COORDINATOR SUPPORT OCT also assists PIs and study coordinators with: Negotiation of Confidentiality and Non-Disclosure Agreements Completion of Site Feasibility Questionnaires Preparation for Sponsor s Pre-Site Selection Visits (PSSV) Preparation for Sponsor s Site Initiation Visits (SIV) Preparation for Sponsor s Close-Out Visits (COV) PATIENT ENROLLMENT AND SUBJECT RECRUITMENT An OCT Recruitment Specialist works with the PI to generate a formal recruitment plan to promote the study, incorporate and disseminate information to other practitioners at Montefiore and Einstein to assist in finding subjects, help to generate study flyers and brochures, formulate advertisements, and employ social media recruitment materials. Contact: OCT@montefiore.org CONTACT US We are here to meet your needs, be they study activation, coordination, recruitment, finances or logistics. Please call upon us, visit with us, and let us know how we can make your work life as a trialist easier. As executive director, I welcome hearing from you. Barrett Katz, MD, MBA Executive Director Office of Clinical Trials bkatz@montefiore.org

Office of Clinical Trials Office of Clinical Trials www.einstein.yu.edu/centers/ictr/clinical-trials 718-920-2000 Office 718-515-6039 Fax Montefiore West Campus Moses Research Tower 8th Floor, Room 8-014 OCT@montefiore.org Einstein East Campus Mazer Building 5th Floor, Room 527 OCT@einstein.yu.edu The Office of Clinical Trials on YouTube: http://www.youtube.com/watch?v=qvva4eei-ei Clinical Trials Where World Class Care Begins